Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes
Related Experiment Video
Updated: May 6, 2026

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
Published on: November 25, 2022
Claudia Hammerschmidt1, Arno Koenigs, Corinna Siegel
1Institute of Medical Microbiology and Infection Control, University Hospital of Frankfurt, Frankfurt, Germany.
Insights
Complement regulator factor H and plasminogen binding by Lyme disease spirochete CspA orthologs are key immune evasion strategies. These molecules inhibit complement activation at multiple levels, protecting the spirochetes from host immune responses.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- CspA is a crucial immune evasion molecule for Lyme disease spirochetes, protecting them from complement-mediated killing.
- Previous research on CspA has primarily focused on Borrelia burgdorferi.
Purpose of the Study:
- To investigate the binding capacities of CspA orthologs from Borrelia burgdorferi, B. afzelii, and B. spielmanii for complement regulator factor H and plasminogen.
- To assess the ability of these CspA orthologs to inhibit complement activation through plasma protein binding or direct interaction with the terminal complement complex.
- To evaluate the in vivo function of CspA orthologs in conferring serum resistance.
Main Methods:
- Ectopic production of functional CspA orthologs in a serum-sensitive B. garinii strain to assess in vivo serum resistance.
- Investigation of recombinant CspA orthologs to analyze complement inhibition and C3b inactivation via factor H and plasminogen binding.
- Comparative analysis of binding affinities and inhibitory capacities among different CspA orthologs.
Main Results:
- All three CspA orthologs (from B. burgdorferi, B. afzelii, and B. spielmanii) conferred resistance to complement-mediated killing when expressed in a serum-sensitive B. garinii strain.
- All CspA orthologs simultaneously bound factor H and plasminogen.
- CspA of B. afzelii demonstrated more efficient plasminogen binding and inhibition of the terminal complement complex compared to orthologs from B. burgdorferi and B. spielmanii.
Conclusions:
- CspA orthologs from serum-resistant Lyme disease spirochetes function as multifunctional immune evasion molecules.
- These molecules inhibit complement activation at two critical levels: C3b generation and terminal complement complex assembly.
- Differences in binding and inhibitory capacities among CspA orthologs highlight species-specific variations in immune evasion strategies.
Abstract:
CspA of the Lyme disease spirochete Borrelia burgdorferi represents a key molecule in immune evasion, protecting borrelial cells from complement-mediated killing. As previous studies focused almost exclusively on CspA of B. burgdorferi, here we investigate the different binding capacities of CspA orthologs of Borrelia burgdorferi, B. afzelii, and B. spielmanii for complement regulator factor H and plasminogen and their ability to inhibit complement activation by either binding these host-derived plasma proteins or independently by direct interaction with components involved in formation of the lethal, pore-like terminal complement complex. To further examine their function in serum resistance in vivo, a serum-sensitive B. garinii strain was used to generate spirochetes, ectopically producing functional CspA orthologs. Irrespective of their species origin, all three CspA orthologs impart resistance to complement-mediated killing when produced in a serum-sensitive B. garinii surrogate strain. To analyze the inhibitory effect on complement activation and to assess the potential to inactivate C3b by binding of factor H and plasminogen, recombinant CspA orthologs were also investigated. All three CspA orthologs simultaneously bound factor H and plasminogen but differed in regard to their capacity to inactivate C3b via bound plasmin(ogen) and inhibit formation of the terminal complement complex. CspA of B. afzelii binds plasmin(ogen) and inhibits the terminal complement complex more efficiently than CspA of B. burgdorferi and B. spielmanii. Taken together, CspA orthologs of serum-resistant Lyme disease spirochetes act as multifunctional evasion molecules that inhibit complement on two central activation levels, C3b generation and assembly of the terminal complement complex.
Related Concept Videos
Complement System
Bacterial Phylum Spirochaetes
Regulation of Bacterial Virulence
Clinical Significance of Antibiotic Resistance
cAMP-dependent Protein Kinase Pathways
Inhibitors of Gram-positive Cell Wall Synthesis

